Bulls N' Bears - Latest Public Company News

We’re sorry, this feature is currently unavailable. We’re working to restore it. Please try again later.

Business

Bulls N' Bears

Advertisement

Brought to you by Bulls N' BearsBulls N' Bears

Westgold amasses $238m after four solid gold mining quarters

Westgold amasses $238m after four solid gold mining quarters

Westgold Resources has amassed a $238 million war chest after four quarters of successful gold mining at its Western Australian operations.

  • by Michael Philipps

Latest

Mercedes edges closer to battery recycling with $30m Neometals order

Mercedes edges closer to battery recycling with $30m Neometals order

Neometals has landed a second order from automotive goliath Mercedes Benz to finalise the two-stage build of a lithium battery recycling plant.

  • by Doug Bright
ClearVue unveils first Aussie solar window manufacturer

ClearVue unveils first Aussie solar window manufacturer

ClearVue Technologies is set to establish its first supply chain on home soil for its remarkable solar window glass that can produce energy from the sun.

  • by Doug Bright
Giant nickel numbers underpin Ardea share price hike

Giant nickel numbers underpin Ardea share price hike

What made share prices jump in 2023? Bulls N’ Bears takes a look at Ardea Resources’ almost biblical-scale PFS numbers that led to a 171 per cent rise.

  • by Andrew Duffy
Novo $10m deal with lithium giant a sign of the times

Novo $10m deal with lithium giant a sign of the times

Novo Resources will partner with lithium mega-miner SQM who will pay $10m to pick up 75 per cent of Novo’s promising lithium/nickel ground in WA’s Pilbara region.

  • by Michael Philipps
Imugene bowel cancer vaccine trial a potential game changer

Imugene bowel cancer vaccine trial a potential game changer

ASX-listed biotech firm Imugene is undertaking phase two trials of its “PD1-Vaxx” treatment for bowel cancer across two continents.

  • by Michael Philipps
Advertisement
Radiopharm increases focus on new lung cancer treatment

Radiopharm increases focus on new lung cancer treatment

Radiopharm Theranostics is about to begin human trials of its promising RAD 204 lung cancer treatment in both Perth and Brisbane.

  • by Doug Bright
A “wunch of bankers”

A “wunch of bankers”

Twigger’s Tales regales readers with fond memories of the tsunami of foreign and other banks that fell victim to the Bell/Bond debacle of the 80s and 90s.

  • by Liam Twigger
Uranium price hikes tantalise ASX-listed juniors

Uranium price hikes tantalise ASX-listed juniors

With the uranium price touching US$90, a bevy of ASX-listed small caps are lining up for a piece of the action and Dollar Bill reckons it’s about time.

  • by Bill McConnell
Time… the ultimate deal killer

Time… the ultimate deal killer

Bookbuilds and Banter with Boz talks billionaires and battery metals as he laments the ultimate killer of the deal – time.

  • by Davide Bosio
Battery giants get set in St George Mining for big 2024

Battery giants get set in St George Mining for big 2024

2023 was a big year for battery metals explorer St George Mining who was courted by two of the world’s largest lithium battery players.

  • by Craig Nolan